Cooley’s 2023 Life Sciences M&A Year in Review: Potent Mix of Creativity and Resilience Spurs Activity Heading Into 2024
Cooley M&A
JANUARY 23, 2024
Sponsor-led take-private transactions – and hostile takeovers – come to life sciences So-called take-private transactions led by a private equity sponsor have become a hot topic in healthcare. billion, while EQT acquired Dechra Pharma, a veterinary products business, in an all-cash acquisition for $6.1 billion.
Let's personalize your content